IRCT2014102619678N1CompletedPhase 1
Efficacy of fluoroquinolones in treating interferon non-responders infected with HCV genotype 3a
Higher Education Commission, Pakistan0 sites40 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 25 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •Patient on IFN treatment who have not shown two-log reduction in their HCV load for 3 months
- •HCV-RNA positive
- •Infection with HCV genotype 3a
- •Chronic hepatitis diagnosed by liver ultrasound
- •Pre-cirrhotic, as determined by liver ultrasound
- •Informed consent to participate in the study
- •Exclusion criteria:
- •Known hypersensitivity to fluoroquinolones
- •Infection with HCV genotype other than 3a
- •Pregnant females
- •Concurrent hepatitis B or HIV infection
- •Carcinomatous changes on liver biopsy evident in liver ultrasound
- •History of alcohol or intravenous drug abuse
- •Disinclination to informed consent
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritisJPRN-UMIN000003897Department of Infectious Diseases and Infection Control, Jikei University School of Medicine20
Active, not recruiting
Phase 1
Pharmacokinetic evaluation of fluoroquinolone antibiotics administered intravenously in intensive care patients with normal renal function and with renal hyperfiltratioIntensive care patientsEUCTR2010-019691-70-BEGhent University
Completed
Not Applicable
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus BacteremiaStaphylococcus AureusSepsisBacteremiaEndocarditisNCT00548002University of Helsinki430
Completed
Not Applicable
FQ Restriction for the Prevention of CDIClostridium DifficileClostridium Difficile InfectionC Difficile ColitisNCT03848689University of Wisconsin, Madison5,871
Completed
Not Applicable
Feasibility and efficacy of FOLFIRINOX therapy in patients with borderline resectable pancreatic cancer in the neoadjvant setting.Borderline resectable pancreatic cancerJPRN-UMIN000034509Department of Hepatobiliary Pancreatic Surgery, Saitama Medical Center, Saitama Medical University30